Dapagliflozin for Cardio-renal Protection After ICU Discharge — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Dapagliflozin for Cardio-renal Protection After ICU Discharge — Stella

Recruiting

Back to Heart Failure and Chronic Kidney Disease Post-ICU trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(2 sites)

France

Hospital Saint Louis, Paris

Saint Louis Hospital, Paris

Key details

Phase

Large-scale testing

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment target

~600 participants

Started

December 2025

Primary completion

January 2029

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov